Search - tctmd.com

Displaying 101 - 120 of 139

Sort: Relevancy | Date

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

News Conference News SCAI 2017

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

L.A. McKeown

May 12, 2017

News Daily News

Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing

Todd Neale

April 26, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

Caitlin E. Cox

February 01, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Presentation TCT 2016

Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal Sinus Rhythm

Presenter: John A. Bittl, Daniel I. Simon, Patrick W. Serruys

October 30, 2016

News Industry News

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

October 03, 2016

News Daily News

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

Yael L. Maxwell

August 16, 2016

News Industry News

Abbott Announces Positive Clinical Results from Studies of FIRM-Guided Rotor Ablation for Atrial Fibrillation

June 22, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Daily News

STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased

Michael O'Riordan

May 05, 2016

News Daily News

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Michael O'Riordan

April 18, 2016

News Opinion Fellow Talk

Test Your Knowledge: 10 Essential Questions on the Evolution of Interventional Cardiology

Sarah Elsayed, MD

January 25, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Industry News

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

December 22, 2015

News Industry News

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

September 14, 2015

News Conference News ESC 2015

Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients

L.A. McKeown

August 31, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Industry News

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

June 29, 2015

News Industry News

Sorin Group Announces European Launch of KORA 250, the World’s Smallest Full Body MRI Conditional Pacing System

June 19, 2015

Advertisement

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing

TCTMD’s Top 10 Most Popular Stories for January 2017

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal Sinus Rhythm

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR

Abbott Announces Positive Clinical Results from Studies of FIRM-Guided Rotor Ablation for Atrial Fibrillation

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

STICS: No Benefit to Perioperative Statin Therapy in Cardiac Surgery, but Acute Kidney Injury Risk Increased

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Test Your Knowledge: 10 Essential Questions on the Evolution of Interventional Cardiology

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

Sorin Group Announces European Launch of KORA 250, the World’s Smallest Full Body MRI Conditional Pacing System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content